Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Gastric Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Not applicableLooking for participantsNCT06822413
What this trial is testing

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Who this might be right for
Cancer DiagnosisLiver Cancer, AdultCancer Screening+14 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 600
Testing effectiveness (Phase 2)Study completedNCT04535414
What this trial is testing

Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers

Who this might be right for
Gastric CancerGastric NeoplasmsGastric Adenocarcinoma
National Cancer Institute (NCI) 195
Early research (Phase 1)Ended earlyNCT00023634
What this trial is testing

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Who this might be right for
Brain TumorsGastric CancerOvarian Cancer+1 more
SWOG Cancer Research Network 14
Not applicableUnknownNCT06440018
What this trial is testing

INSPIRE: a Multi-Cancer Early Detection Study

Who this might be right for
Lung CancerGastric CancerLiver Cancer+10 more
Singlera Genomics Inc. 5,350
Not applicableAvailableNCT06048081
What this trial is testing

Early Access Program for Zolbetuximab

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma CancerLocally Advanced Unresectable Gastric Adenocarcinoma CancerMetastatic Gastric Adenocarcinoma Cancer+1 more
Astellas Pharma Global Development, Inc.
Not applicableStudy completedNCT04478175
What this trial is testing

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Who this might be right for
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors
Institut Curie 30
Not applicableUnknownNCT01962519
What this trial is testing

Early Oral Feeding After Total Gastrectomy for Cancer

Who this might be right for
Adenocarcinoma of the Stomach
Jagiellonian University 112
Not applicableLooking for participantsNCT07142122
What this trial is testing

Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 76
Not applicableStudy completedNCT03388047
What this trial is testing

Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus

Who this might be right for
Barrett EsophagusEsophageal NeoplasmsReflux Esophagitis
University of Cambridge 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05713838
What this trial is testing

Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery

Who this might be right for
Esophagus Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Ended earlyNCT04089904
What this trial is testing

Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric AdenocarcinomaEsophageal Adenocarcinoma
University of Chicago 3
Testing effectiveness (Phase 2)Study completedNCT01743469
What this trial is testing

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Who this might be right for
Advanced or Metastatic Hepatocellular CancerAdvanced or Metastatic Ovarian CancerMetastatic Renal Cell Cancer+1 more
Ipsen 201
Not applicableActive Not RecruitingNCT03997162
What this trial is testing

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Who this might be right for
Clinical Stage 0 Gastric Cancer AJCC v8Clinical Stage I Gastric Cancer AJCC v8Clinical Stage II Gastric Cancer AJCC v8+15 more
City of Hope Medical Center 52
Not applicableLooking for participantsNCT07829081
What this trial is testing

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

Who this might be right for
Quality of Life (QOL)Mismatch Repair Deficient Colorectal CancerMicrosatellite Instability-High Colorectal Cancer+8 more
University Hospital, Basel, Switzerland 234
Not applicableLooking for participantsNCT07714538
What this trial is testing

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

Who this might be right for
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric Adenocarcinoma+4 more
Imperial College London 1,000